Social networks
4,621Activities
Technologies
Entity types
Location
Forskargatan 20C, 151 36 Södertälje, Sweden
Södertälje
Sweden
Employees
Scale: 51-200
Estimated: 105
Engaged corporates
0Added in Motherbase
1 year, 3 months agoEngineered Immunity
Anocca understands the complexity of T-cell biology. We have established a unique technology platform that replicates functional human cellular immunobiology and unlocks the potential of T-cell immunotherapies and vaccine strategies that leverage T-cell immunity.
Anocca’s approach and proprietary technologies deliver the means to efficiently and precisely harness and manipulate T-cell immunity, enabling a range of next-generation therapies and vaccination strategies that address unmet patient need in oncology, infectious disease and autoimmunity.
Today Anocca has a focus on delivering T-cell receptor-modified T-cell therapies (TCR-T) in oncology. Anocca is rapidly progressing a pipeline of novel therapeutic TCR-T candidates generated entirely with our own technologies towards clinical trials utilising our in-house state-of-the-art manufacturing capabilities and processes.
Biotechnology, Immunotherapeutics, Drug Discovery, Drug Development, Immunology, Immunotechnology, and Immuno-Oncology
Anocca is creating a pipeline of precision T-cell immunotherapies by combining its novel approach to T-cell biology, cutting-edge biotechnologies and integrated software. Our primary focus is to engineer TCR-T cell therapies for untreatable cancers.